Stonebrook Private’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
4,755
-163
-3% -$45.1K 0.19% 81
2026
Q1
$1.45M Sell
4,918
-157
-3% -$46.6K 0.31% 67
2025
Q4
$1.39M Sell
5,075
-7,354
-59% -$2M 0.29% 64
2025
Q3
$3.36M Buy
12,429
+218
+2% +$59.3K 0.73% 34
2025
Q2
$3.36M Buy
12,211
+188
+2% +$51.1K 0.79% 26
2025
Q1
$3.19M Sell
12,023
-171
-1% -$42.2K 0.83% 30
2024
Q4
$2.83M Sell
12,194
-265
-2% -$60.9K 0.74% 34
2024
Q3
$2.75M Sell
12,459
-710
-5% -$147K 0.73% 36
2024
Q2
$2.59M Buy
13,169
+35
+0.3% +$7.23K 0.74% 37
2024
Q1
$2.83M Buy
13,134
+1,274
+11% +$268K 0.82% 33
2023
Q4
$2.5M Buy
+11,860
New +$2.53M 0.83% 33

Other funds holding CME

Stonebrook Private's CME Position: Q2 2026 in Review

Stonebrook Private reduced its CME Group (CME) stake by 3.3% in Q2 2026, selling an estimated $45.1K and leaving 4,755 shares worth $1.05M. The position accounts for 0.19% of the portfolio, ranked #81.

Stonebrook Private first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.36M in Q2 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Stonebrook Private held 4,755 shares of CME Group worth $1.05M as of Q2 2026.
  • Stonebrook Private sold 163 CME Group shares in Q2 2026, an estimated $45.1K.
  • CME Group made up 0.19% of Stonebrook Private's portfolio in Q2 2026, its #81 holding.
  • Stonebrook Private first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Stonebrook Private's CME Group position peaked at $3.36M in Q2 2025.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Stonebrook Private's 13F filing for Q2 2026, filed 14 Aug 2026.